Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multifocal motor neuropathy

V Chaudhry1

  • 1Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287-6965, USA.

Seminars in Neurology
|May 1, 1998
PubMed
Summary
This summary is machine-generated.

Multifocal motor demyelinating neuropathy causes progressive weakness, often affecting one side. Treatment with immunoglobulin or cyclophosphamide typically improves strength, suggesting an autoimmune cause.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autologous fecal transplant for the treatment of microcolon due to diversion colitis.

Techniques in coloproctology·2021
Same author

Diverticular colovesical fistula: What should we really be doing?

Techniques in coloproctology·2017
Same author

Treatment of fistula-in-ano using a porcine small intestinal submucosa anal fistula plug.

Techniques in coloproctology·2012
Same author

Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Neurology·2012
Same author

Evolution of treatment of fistula in ano.

World journal of surgery·2012
Same author

Evidence-based guideline update: intraoperative spinal monitoring with somatosensory and transcranial electrical motor evoked potentials: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Clinical Neurophysiology Society.

Neurology·2012
Same journal

Isolated Cranial Tremors: A Reappraisal.

Seminars in neurology·2026
Same journal

Dystonia and Tremor.

Seminars in neurology·2026
Same journal

Pendular nystagmus and oculopalatal tremor.

Seminars in neurology·2026
Same journal

Sanjay Pandey, MBBS, MD, DNB, DM, FIAN, and Aasef Shaikh, MD, PhD.

Seminars in neurology·2026
Same journal

Tremor.

Seminars in neurology·2026
Same journal

Carotid Disease.

Seminars in neurology·2026
See all related articles

Area of Science:

  • Neurology
  • Immunology

Background:

  • Multifocal motor demyelinating neuropathy (MMDN) is an acquired immune-mediated disorder.
  • It presents with distinct clinical and electrophysiologic features.

Observation:

  • MMDN is characterized by slowly progressive, asymmetrical distal weakness, commonly affecting wrists and feet.
  • Electrophysiologic studies show multifocal motor demyelinating features, with persistent motor conduction block being a key indicator.
  • Sensory nerve conduction studies are typically normal.

Findings:

  • Patients often exhibit significant strength improvement following treatment with intravenous human immunoglobulin or cyclophosphamide.
  • Serum anti-GM1 ganglioside antibodies are frequently detected in affected individuals.
  • An autoimmune pathogenesis is strongly suggested by treatment response and antibody presence.

Related Experiment Videos

Implications:

  • Understanding the autoimmune basis of MMDN guides therapeutic strategies.
  • Early diagnosis and immunomodulatory treatment can significantly improve patient outcomes.
  • Further research into MMDN pathogenesis may reveal novel therapeutic targets.